Search
Search
Join Thermo Fisher Scientific at the 115th USCAP Annual Meeting, held from March 21st to 26th in San Antonio, Texas. Visit us at booth # 423 for a live look at the end-to-end Ion Torrent Genexus System, featuring the Genexus Purification System and Genexus Integrated Sequencer. See firsthand how the Genexus System can deliver sample-to-report results in as little as 24 hours across a broad range of oncology research applications.
Date: Wednesday, March 25th
Time: 12:00 PM – 1:00 PM (CST)
Location: Exhibit Seminar Room 3
Kritika Krishnamurthy, MD
Assistant Professor, Pathology, Montefiore Medical Center
Albert Einstein College of Medicine
Wei Song, MD, PhD
Associate Clinical Professor of Pathology, Director, Clinical Genomics and Molecular Pathology, Program Director, Molecular Genetics Pathology Fellowship
Department of Pathology, University of California San Diego School of Medicine
A myeloid genomic profiling solution that can deliver an NGS report, covering key DNA and RNA targets, in as little as 24 hours on the Ion Torrent Genexus System.
A DNA and RNA assay for comprehensive myeloid MRD analysis using highly sensitive AmpliSeq HD technology which enables a limit of detection as low as 0.05% allele frequency.
Advanced NGS solutions that can sequence multiple B- and T-cell receptor targets in a single reaction for highly sensitive and specific clone detection.
Profile a range of lymphoid mutations in a single test in as little as 24 hours and access a community network of leading researchers.
The Ion Torrent Genexus System is the only turnkey next-generation sequencing (NGS) solution that automates the end-to-end workflow from the biological specimen all the way to the final report and delivers results in as little as 24 hours.
Thinking about how the Genexus System works and how it could fit into your lab? In our virtual laboratory environment powered by augmented reality (AR) technology, you can see:
For Research Use Only. Not for use in diagnostic procedures.
PMR-002675